Baron Financial Group, LLC Merck & Co., Inc. Transaction History

Baron Financial Group, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$108.61 - $118.38 $3,149 - $3,433	-29 Reduced 1.43%	1,993 $229,000
Q1 2023 Apr 06, 2023	BUY	$102.94 - $114.86 $2,264 - $2,526	22 Added 1.1%	2,022 $215,000
Q4 2022 Jan 20, 2023	BUY	$87.44 - $112.11 $174,880 - $224,220	2,000 New	2,000 $0
Q1 2022 May 13, 2022	SELL	$73.51 - $82.4 $4,998 - $5,603	-68 Reduced 3.12%	2,110 $173,000
Q4 2021 Feb 09, 2022	BUY	$72.28 - $90.54 $722 - $905	10 Added 0.46%	2,178 $166,000
Q3 2021 Nov 12, 2021	BUY	$71.68 - $78.83 $7,168 - $7,883	100 Added 4.84%	2,168 $162,000
Q1 2021 May 13, 2021	BUY	$68.86 - $81.11 $20,658 - $24,333	300 Added 16.97%	2,068 $159 Million
Q3 2020 Nov 13, 2020	BUY	$73.18 - $82.95 $129,382 - $146,655	1,768 New	1,768 $139,000

3,826

1.91B

13.4M

10.7M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $278B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Baron Financial Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Baron Financial Group, LLC with notifications on news.